Takeda Pharmaceutical Co Ltd (FRA:TKDA)
€ 12.7 -0.2 (-1.55%) Market Cap: 40.26 Bil Enterprise Value: 68.39 Bil PE Ratio: 45.03 PB Ratio: 0.85 GF Score: 75/100

Q2 2020 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript

Oct 31, 2019 / 08:45AM GMT
Release Date Price: €16 (+1.27%)

Oct 31, 2019 / 08:45AM GMT
Presentation
Oct 31, 2019 / 08:45AM GMT

=====================
Corporate Participants
=====================
* Andrew S. Plump
Takeda Pharmaceutical Company Limited - President of Research & Development and Director
* Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director
* Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Director
* Masato Iwasaki
Takeda Pharmaceutical Company Limited - President of Japan Pharma Business Unit & Director
* Takashi Okubo
Takeda Pharmaceutical Company Limited - Global Head of IR, Global Finance

=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc, Research Division - MD and Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Shinichiro Muraoka
Morgan Stanley, Research

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot